• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Addressing the Complications of Ebola and Other Viral Hemorrhagic Fever Infections: Using Insights from Bacterial and Fungal Sepsis.

作者信息

Hellman Judith

机构信息

Department of Anesthesia and Perioperative Care, Division of Critical Care Medicine Faculty, Biomedical Sciences and Immunology Programs, University of California, San Francisco, San Francisco, California, United States of America.

出版信息

PLoS Pathog. 2015 Oct 1;11(10):e1005088. doi: 10.1371/journal.ppat.1005088. eCollection 2015 Oct.

DOI:10.1371/journal.ppat.1005088
PMID:26425845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4591006/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9671/4591006/4274bfa783bc/ppat.1005088.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9671/4591006/4274bfa783bc/ppat.1005088.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9671/4591006/4274bfa783bc/ppat.1005088.g001.jpg

相似文献

1
Addressing the Complications of Ebola and Other Viral Hemorrhagic Fever Infections: Using Insights from Bacterial and Fungal Sepsis.应对埃博拉及其他病毒性出血热感染的并发症：借鉴细菌和真菌败血症的见解
PLoS Pathog. 2015 Oct 1;11(10):e1005088. doi: 10.1371/journal.ppat.1005088. eCollection 2015 Oct.
2
Evaluation of cryptic fever in a traveler to Africa.一名前往非洲旅行者的隐匿性发热评估
Curr Clin Top Infect Dis. 1992;12:329-47.
3
Bacterial co-infection is rare in patients with Ebola virus disease in a military Ebola virus disease treatment unit in Sierra Leone.在塞拉利昂一个军事埃博拉病毒病治疗单位中，埃博拉病毒病患者发生细菌合并感染的情况较为罕见。
J Infect. 2015 Sep;71(3):406-7. doi: 10.1016/j.jinf.2015.03.004. Epub 2015 Mar 27.
4
Infectious complications in the elderly diabetic patient.老年糖尿病患者的感染性并发症
Geriatrics. 1983 Feb;38(2):63-6, 71-2.
5
[Viral hemorrhagic fever].[病毒性出血热]
Ned Tijdschr Geneeskd. 1998 Feb 28;142(9):448-51.
6
[Viral hemorrhagic fever--Ebola hemorrhagic fever, Marburg disease and Lassa fever].[病毒性出血热——埃博拉出血热、马尔堡病和拉沙热]
Rinsho Byori. 1998 Jul;46(7):651-5.
7
[Fever in treated and untreated leukemias and hematosarcomas].
Acta Clin Belg. 1973;28(2):129-35. doi: 10.1080/17843286.1973.11716864.
8
The hemorrhagic fevers of Southern Africa with special reference to studies in the South African Institute for Medical Research.南非的出血热，特别提及南非医学研究所的研究
Yale J Biol Med. 1982 May-Aug;55(3-4):207-12.
9
Non-specific anti-viral approach towards Ebola virus infection: a comment on "Against Ebola: type I interferon guard risk and mesenchymal stromal cell combat sepsis".针对埃博拉病毒感染的非特异性抗病毒方法：对《对抗埃博拉：I型干扰素防范风险，间充质基质细胞对抗脓毒症》的评论
J Zhejiang Univ Sci B. 2015 Mar;16(3):251-2. doi: 10.1631/jzus.B1500035.
10
Oral Complications of Systemic Bacterial and Fungal Infections.
Atlas Oral Maxillofac Surg Clin North Am. 2017 Sep;25(2):209-220. doi: 10.1016/j.cxom.2017.04.012.

引用本文的文献

1
Caseload and Case Fatality of Lassa Fever in Nigeria, 2001-2018: A Specialist Center's Experience and Its Implications.2001 - 2018年尼日利亚拉沙热的病例数及病死率：一家专科中心的经验及其启示
Front Public Health. 2019 Jun 25;7:170. doi: 10.3389/fpubh.2019.00170. eCollection 2019.
2
Characterization of Pathogenic Sepsis Etiologies and Patient Profiles: A Novel Approach to Triage and Treatment.致病性脓毒症病因及患者概况的特征分析：一种分诊与治疗的新方法
Microbiol Insights. 2019 Jan 27;12:1178636118825081. doi: 10.1177/1178636118825081. eCollection 2019.
3
Epidemiology and Immune Pathogenesis of Viral Sepsis.

本文引用的文献

1
Liberia confirms Ebola case two months after being declared free of the disease.利比里亚在宣布摆脱埃博拉疫情两个月后，又确诊了一例埃博拉病例。
BMJ. 2015 Jul 2;350:h3620. doi: 10.1136/bmj.h3620.
2
Treating the Host Response to Ebola Virus Disease with Generic Statins and Angiotensin Receptor Blockers.使用通用他汀类药物和血管紧张素受体阻滞剂治疗宿主对埃博拉病毒病的反应。
mBio. 2015 Jun 23;6(3):e00716. doi: 10.1128/mBio.00716-15.
3
Statin therapy in critically-ill patients with severe sepsis: a review and meta-analysis of randomized clinical trials.
病毒败血症的流行病学和免疫发病机制。
Front Immunol. 2018 Sep 27;9:2147. doi: 10.3389/fimmu.2018.02147. eCollection 2018.
4
Disabling of lymphocyte immune response by Ebola virus.埃博拉病毒对淋巴细胞免疫反应的抑制作用。
PLoS Pathog. 2018 Apr 12;14(4):e1006932. doi: 10.1371/journal.ppat.1006932. eCollection 2018 Apr.
5
Multi-platform 'Omics Analysis of Human Ebola Virus Disease Pathogenesis.多平台人类埃博拉病毒病发病机制的“组学”分析。
Cell Host Microbe. 2017 Dec 13;22(6):817-829.e8. doi: 10.1016/j.chom.2017.10.011. Epub 2017 Nov 16.
6
Contrasting academic and lay press print coverage of the 2013-2016 Ebola Virus Disease outbreak.2013 - 2016年埃博拉病毒病疫情学术媒体与大众媒体印刷报道的对比。
PLoS One. 2017 Jun 22;12(6):e0179356. doi: 10.1371/journal.pone.0179356. eCollection 2017.
7
Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection.尽管没有感染，但埃博拉病毒糖蛋白直接引发T淋巴细胞死亡。
PLoS Pathog. 2017 May 22;13(5):e1006397. doi: 10.1371/journal.ppat.1006397. eCollection 2017 May.
8
Insights from clinical research completed during the west Africa Ebola virus disease epidemic.西非埃博拉病毒病疫情期间完成的临床研究见解。
Lancet Infect Dis. 2017 Sep;17(9):e280-e292. doi: 10.1016/S1473-3099(17)30234-7. Epub 2017 Apr 28.
9
The Toll-Like Receptor 4 Antagonist Eritoran Protects Mice from Lethal Filovirus Challenge.Toll样受体4拮抗剂埃瑞托单抗可保护小鼠免受致死性丝状病毒攻击。
mBio. 2017 Apr 25;8(2):e00226-17. doi: 10.1128/mBio.00226-17.
10
Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola.应对宿主对新发病毒疾病的反应：从脓毒症、肺炎、流感和埃博拉疫情中汲取的经验教训。
Ann Transl Med. 2016 Nov;4(21):421. doi: 10.21037/atm.2016.11.03.
他汀类药物治疗重症脓毒症患者：随机临床试验的综述与荟萃分析
Minerva Anestesiol. 2015 Aug;81(8):921-30. Epub 2015 Feb 18.
4
Ebola in Freetown area, Sierra Leone--a case study of 581 patients.塞拉利昂弗里敦地区的埃博拉疫情——581例患者的案例研究
N Engl J Med. 2015 Feb 5;372(6):587-8. doi: 10.1056/NEJMc1413685. Epub 2014 Dec 24.
5
West African Ebola epidemic after one year--slowing but not yet under control.西非埃博拉疫情一年后——疫情减缓但尚未得到控制。
N Engl J Med. 2015 Feb 5;372(6):584-7. doi: 10.1056/NEJMc1414992. Epub 2014 Dec 24.
6
Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care.严重埃博拉病毒病伴血管渗漏和多器官衰竭：重症监护患者的治疗。
Lancet. 2015 Apr 11;385(9976):1428-35. doi: 10.1016/S0140-6736(14)62384-9. Epub 2014 Dec 19.
7
Statin therapy and mortality from sepsis: a meta-analysis of randomized trials.他汀类药物治疗与脓毒症死亡率：随机试验的荟萃分析。
Am J Med. 2015 Apr;128(4):410-7.e1. doi: 10.1016/j.amjmed.2014.10.057. Epub 2014 Dec 17.
8
Shed GP of Ebola virus triggers immune activation and increased vascular permeability.埃博拉病毒的脱落糖蛋白引发免疫激活并增加血管通透性。
PLoS Pathog. 2014 Nov 20;10(11):e1004509. doi: 10.1371/journal.ppat.1004509. eCollection 2014 Nov.
9
The pro-resolving lipid mediator maresin 1 (MaR1) attenuates inflammatory signaling pathways in vascular smooth muscle and endothelial cells.促消退脂质介质maresin 1（MaR1）可减弱血管平滑肌和内皮细胞中的炎症信号通路。
PLoS One. 2014 Nov 19;9(11):e113480. doi: 10.1371/journal.pone.0113480. eCollection 2014.
10
Clinical care of two patients with Ebola virus disease in the United States.美国两例埃博拉病毒病患者的临床护理。
N Engl J Med. 2014 Dec 18;371(25):2402-9. doi: 10.1056/NEJMoa1409838. Epub 2014 Nov 12.